Aurinia Pharmaceuticals Stock Surges Post-Upgrade: What’s Driving AUPH’s Rise?
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) recently experienced a notable surge in its stock price, reflecting renewed investor confidence and a significant vote of approval from financial analysts….
Aurinia Pharmaceuticals: HC Wainwright’s Q2 Earnings Estimate Unpacked
In a significant development for the biotechnology sector, analysts at HC Wainwright have released their comprehensive Q2 2025 earnings per share (EPS) estimates for Aurinia Pharmaceuticals Inc.,…